Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapy
Authors:
Open Access
- 5 November 2025
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 138, 112213
Abstract
No abstract availableKeywords
Funding Information
- Gansu Provincial Natural Science Foundation (17JR5RA272)
- Gansu Provincial Natural Science Foundation (22JR5RA923)
- Lanzhou University First Hospital
- Lanzhou University (Ldyyyn2021\u201330)
- Lanzhou University (Ldyyyn2021\u2013120)
This publication has 141 references indexed in Scilit:
- Breaking Boundaries: Chronic Diseases and the Frontiers of Immune MicroenvironmentsMed Research, 2025
- Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular SubtypesMed Research, 2025
- What Is Thyroid Cancer?JAMA, 2024
- Thyroid CancerJAMA, 2024
- The molecular classification of cancer‐associated fibroblasts on a pan‐cancer single‐cell transcriptional atlasClinical and Translational Medicine, 2023
- Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectivesCancer Communications, 2022
- Multicompartment metabolism in papillary thyroid cancerThe Laryngoscope, 2015
- Stromal myofibroblasts are drivers of invasive cancer growthInternational Journal of Cancer, 2008
- Gefitinib Inhibition of Drug Resistance to Doxorubicin by Inactivating ABCG2 in Thyroid Cancer Cell LinesJAMA Otolaryngology–Head & Neck Surgery, 2007
- Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: evidence for a dual action of tumour cells in collagen type I synthesisThe Journal of Pathology, 2000